Logo image
Development of a biological at-risk volume using apparent diffusion coefficient for parotid-sparing radiation therapy planning
Journal article   Open access   Peer reviewed

Development of a biological at-risk volume using apparent diffusion coefficient for parotid-sparing radiation therapy planning

Katelyn Cahill, Catriona Hargrave, Patrick O’Connor, Mark Denham, Nathan Hearn, Dinesh Vignarajah, Zack Y Shan and Myo Min
BJR Open, Vol.7(1), pp.1-8
2025
PMCID: PMC12401576
PMID: 40901382
pdf
tzaf0201.10 MBDownloadView
Published VersionCC BY V4.0 Open Access

Abstract

apparent diffusion coefficient diffusion-weighted MRI biological at-risk volume head and neck cancer parotid gland radiotherapy Thompson Institute Special Collection Other Collaborations
Objectives Xerostomia toxicity continues to contribute towards a decrease in quality of life in head and neck cancer patients. Diffusion weighted MRI and the associated apparent diffusion coefficient (ADC) may identify the radiosensitive region within the parotid gland (PG). This study retrospectively assesses the feasibility of using percentile threshold values from the ADC map to generate a biological at-risk volume (BRV). The location and distribution of BRV are evaluated across the PG. Methods Image registration between the planning CT and MRI-simulation images was performed and reviewed to ensure accurate translation of ADC data when contouring the PG. Histogram analysis was undertaken using the 20th, 30th, and 50th percentile ADC values of each contoured PG to form the BRV. The whole PG was split into 8 anatomical sectors at a common intersection point to evaluate the distribution of BRV throughout. Results The BRV distribution for each percentile was mapped across the whole contoured PG and each anatomical sector contour. The largest distribution was predominantly found in the superolateral sectors. Conclusions The 20th and 30th percentile ADC values can be used to form a BRV of the PG. The location of the BRV distribution indicates a potential relationship between ADC thresholds and the functional region of the PG. Advances in knowledge The BRV is located in a favourable position within the PG and could be used to further spare this salivary gland during dose optimization. The feasibility of this approach will be explored in a future retrospective dosimetry study.

Details

Metrics

16 File views/ downloads
46 Record Views
Logo image